← SynDRA
SEPANTRONIUM
SynDRA canonical compound SYN0033403 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | BIRC5 |
| Mechanism of action | Survivin inhibitor |
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- SLC47A2
- HDAC6
- ILF3
- PAK1
- RIPK2
- SLC47A1
- SP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ALAT2
- ATXN2
- FUMH
- HLAB
- HTT
- IFNB1
- IFNG
- KSYK
- MITF
- NSD2
- PARP1
- SNCA
- SYK
- SYUA
- TFE3
Cross-references
Synonyms
- Sepantronium cation
- Sepantronium ion
- YM-155
- UZ77T1VFBM
- CHEBI:94552
- RefChem:931620
- DTXCID70148807
- Sepantronium [USAN]
- UNII-UZ77T1VFBM
- GXU
- SEPANTRONIUM [WHO-DD]
- SCHEMBL2814857
- SCHEMBL6188375
- SCHEMBL29464041
- BDBM420311
- BDBM50468263
- BDBM50594452
- NSC755387
- NSC764936
- NSC-755387
- NSC-764936
- NCGC00242514-01
- NCGC00242514-15
- BRD-K24681473-004-01-4
- BRD-K76703230-001-01-3
- BRD-K76703230-004-03-3
- BRD-K76703230-004-04-1
- SCHEMBL29493286
- YM-155; Sepantronium bromide
- AS-17057
- HMS3751C03
- sepantronii bromidum
- YM155?
- YM155
- C20H19BrN4O3
- Z2037281428
- Sepantronium bromide (JAN/USAN)
Look up SEPANTRONIUM in the interactive SynDRA portal →